As the global economy mends, the 2021 growth of Gamma-aminobutyric Acid (GABA) Receptor Agonist will have significant change from previous year. According to our researcher latest study, the global Gamma-aminobutyric Acid (GABA) Receptor Agonist market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Gamma-aminobutyric Acid (GABA) Receptor Agonist market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Gamma-aminobutyric Acid (GABA) Receptor Agonist market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Gamma-aminobutyric Acid (GABA) Receptor Agonist market, reaching US$ million by the year 2028. As for the Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Gamma-aminobutyric Acid (GABA) Receptor Agonist players cover Sanofi, Mylan N.V., Teva Pharmaceutical Industries, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Gamma-aminobutyric Acid (GABA) Receptor Agonist market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Oral

Parenteral

Intrathecal

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospitals

Specialty Clinics

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Sanofi

Mylan N.V.

Teva Pharmaceutical Industries

Novartis

Aytu BioScience

Dr. Reddy’s Laboratories

Endo Pharmaceuticals

Lupin

Johnson & Johnson Services

Lannett

Sun Pharmaceutical Industries

Cipla

Aurobindo Pharma

Zydus Cadila